September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 10, 2025

Medical Societies Challenge Kennedy

"That you can no longer trust the recommendations out of the CDC is just devastating."

Conexiant

September 10, 2025

Global Asthma Burden Projected to Decline by 2030

Asthma incidence and prevalence set to decrease globally, with notable exceptions in adolescents and regional differences emerging.

Conexiant

September 10, 2025

Study Ties Diet to Lung Cancer Risk

High consumption of ultra-processed foods was associated with increased risk of lung cancer, including both non-small cell and small cell subtypes.

Conexiant

September 05, 2025

Dr. Jordan Strom Lays the Scene for ASE 2025

As ASE marks its 50th anniversary in Nashville, the meeting will showcase the latest echocardiography research, updated guidelines, the Kalmanson Lecture, and discussions on workforce challenges.

Conexiant

September 03, 2025

FDA Approves Denosumab Biosimilars

The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.

Conexiant

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

September 02, 2025

Pediatric Sepsis Outcomes by EBV Serostatus

Patients who were Epstein-Barr virus seropositive showed higher levels of immune dysregulation markers.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant